{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["saline exposure", "LPS exposure"], "o": []}
{"i": ["non - insulin - stimulated", "hyperinsulinemic euglycemic clamp"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["Abdominal subcutaneous adipose tissue"]}
{"i": [], "o": ["sCD163 concentrations", "plasma sCD163 levels", "plasma concentration of free fatty acids , Rapalmitate , lipid oxidation rates and phosphorylation of the hormone - sensitive lipase"]}
{"i": [], "o": ["sCD163 concentrations", "plasma concentrations of cortisol , glucagon , tumour necrosis factor ( TNF )- \u03b1 , interleukin ( IL )- 6 and IL - 10"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["saline exposure", "LPS exposure"], "o": []}
{"i": ["non - insulin - stimulated", "hyperinsulinemic euglycemic clamp"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["Abdominal subcutaneous adipose tissue"]}
{"i": [], "o": ["sCD163 concentrations", "plasma sCD163 levels", "plasma concentration of free fatty acids , Rapalmitate , lipid oxidation rates and phosphorylation of the hormone - sensitive lipase"]}
{"i": [], "o": ["sCD163 concentrations", "plasma concentrations of cortisol , glucagon , tumour necrosis factor ( TNF )- \u03b1 , interleukin ( IL )- 6 and IL - 10"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["circulating free fatty acid ( FFA ) levels"]}
{"i": ["LPS"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["shedding of sCD163"]}
{"i": ["lipopolysaccharide ( LPS )"], "o": ["insulin resistance", "lipolysis rates"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["plasma sCD163"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["Saline ( placebo )."], "o": []}
{"i": ["amino acid supplementation"], "o": []}
{"i": [], "o": []}
{"i": ["LPS .", "LPS", "placebo"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["non - insulin - stimulated", "hyperinsulinemic euglycemic clamp"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["saline", "LIPOPOLYSACCHARIDE ( LPS ):", "Escherichia coli endotoxin"], "o": []}
{"i": ["saline", "placebo"], "o": []}
{"i": [], "o": []}
{"i": ["Insulin"], "o": []}
{"i": [], "o": ["plasma glucose concentrations", "Plasma glucose concentrations"]}
{"i": [], "o": ["glucose infusion rate ( GIR )"]}
{"i": ["placebo"], "o": ["GIR"]}
{"i": [], "o": []}
{"i": [], "o": ["\u03b2 - hydroxybutyrate", "glucagon", "lactate and glucose", "Serum concentrations of cortisol"]}
{"i": [], "o": ["Serum concentrations of tumour necrosis factor alpha ( TNF - \u03b1 ), interleukin ( IL )- 6 and IL - 10"]}
{"i": [], "o": ["sCD163"]}
{"i": ["3H - palmitate", "palmitate ( Rapalmitate )"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["relative content and phosphorylation"]}
{"i": [], "o": []}
{"i": ["Oxycon Pro calorimeter"], "o": []}
{"i": [], "o": ["resting energy expenditure", "respiratory quotient"]}
{"i": [], "o": ["Fat oxidation rates"]}
{"i": [], "o": ["calorimetry"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["sCD163 concentrations"]}
{"i": [], "o": []}
{"i": [], "o": ["\u0394GIR and \u0394sCD163"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["SCD163"], "o": []}
{"i": [], "o": ["mean plasma concentration"]}
{"i": ["LPS", "placebo"], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["placebo"], "o": ["change in glucose infusion rates", "plasma concentrations of sCD163"]}
{"i": [], "o": ["\u0394sCD163 and \u0394GIR"]}
{"i": [], "o": []}
{"i": [], "o": ["\u0394GIR ( insulin resistance ) and \u0394sCD163 ( B )."]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["LPS", "placebo"], "o": ["plasma concentrations of \u03b2 - hydroxybutyrate ( BHB )", "plasma concentrations of free fatty acids ( FFAs ), ( B ) lipid oxidation rates , ( C ) rate of appearance for palmitat ( Rapalmitat ), ( D ) ratio of phosphorylated hormone - sensitive lipase at ser660 ( HSL ) to content of HSL ( pHSL / HSL )", "concentrations of sCD163"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": ["LPS", "placebo"], "o": ["peak plasma concentrations of ( A ) interleukin ( IL )- 6 , ( B ) IL - 10 , ( C ) tumour necrotic factor ( TNF )- \u03b1 , ( D ) cortisol and ( E ) glucagon", "peak plasma concentrations of sCD163"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["sCD163 concentrations"]}
{"i": [], "o": ["sCD163 and insulin resistance"]}
{"i": [], "o": []}
{"i": [], "o": ["sCD163 concentrations"]}
{"i": [], "o": ["concentrations of both sCD163", "TNF - \u03b1"]}
{"i": ["LPS"], "o": []}
{"i": [], "o": []}
{"i": ["hyperinsulinemic euglycemic clamp technique"], "o": []}
{"i": [], "o": ["insulin resistance", "sCD163"]}
{"i": [], "o": []}
{"i": [], "o": ["insulin resistance", "sCD163"]}
{"i": ["LPS", "placebo"], "o": ["plasma FFA , lipid oxidation , Rapalmitate", "lipolysis"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["circulating levels of FFA", "plasma concentrations of BHB", "plasma concentration of sCD163"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["lipolysis"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["sCD163", "sCD163 levels"]}
{"i": [], "o": []}
{"i": [], "o": ["sCD163"]}
{"i": [], "o": ["inflammatory parameters such as IL - 6 , IL - 10 , cortisol , glucagon , body temperature and heart rate", "sCD163 concentrations", "TNF - \u03b1"]}
{"i": [], "o": ["inflammatory parameters", "sCD163 concentrations"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": ["plasma sCD163 concentrations"]}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
{"i": [], "o": []}
